Ignite Creation Date:
2024-05-06 @ 6:27 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05664139
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-08
First Post:
2022-12-08
Brief Title:
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
Sponsor:
Organization:
Fujian Cancer Hospital